| 发明名称 |
PHARMACEUTICAL COMPOSITION |
| 摘要 |
<p>The present invention provides a novel means of suppressing the generation of statin lactones. The pharmaceutical composition of the present invention is characterized by containing a compound having HMG-CoA reductase inhibiting activity represented by formula (1), or a salt thereof, and an alkali earth metal chloride salt. In the formula below, R represents an organic group, and X represents -CH2-CH2- or -CH=CH-.</p> |
| 申请公布号 |
WO2012056509(A1) |
申请公布日期 |
2012.05.03 |
| 申请号 |
WO2010JP68864 |
申请日期 |
2010.10.25 |
| 申请人 |
JP;JP;JP;JP |
发明人 |
ARAI, TAKAYUKI;MIURA, SEIJI |
| 分类号 |
A61K31/191;A61K9/20;A61K31/22;A61K31/47;A61P3/06;A61P9/10 |
主分类号 |
A61K31/191 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
